Company: EVLVW
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0001628280-25-021091
Chunk: 8

Company: Evolv Technologies Holdings, Inc.
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 8
---
 OF CONTENTS

#### Governance Best Practices
The following is a summary of our corporate governance practices, which we regularly evaluate and update through stockholder engagement and evolving practices.

| Board Practices |     |                                                                                                 |     |                                                                                               |
|                 |     | PCommitted to board refreshment, including the appointment of a new director                    |     | PPartners with external advisors to holistically evaluate Board composition and effectiveness |
|                 |     | PAnnual board self-evaluation process overseen by Nominating and Corporate Governance Committee |     | PAnti-hedging and pledging policy                                                             |
|                 |     | PRobust clawback policy                                                                         |     | PStock ownership guidelines for non-employee directors                                        |
|                 |     | PEach director attended at least 75% of Board and committee meetings                            |     |                                                                                               |

| Independent Oversight |     |                                                                                                                 |     |                                                                                                               |
|                       |     | PSeparate CEO and Chair                                                                                         |     | P8 out of 10 directors are independent                                                                        |
|                       |     | PIndependent Chair                                                                                              |     | P100% independent directors on Audit, Compensation and Nominating and Corporate Governance Committees         |
|                       |     | PDedicated Investment Committee tasked with overseeing investment strategy and financial condition developments |     | PRegular executive sessions for independent directors without non-independent directors or management present |
|                       |     | PChief Compliance Officer reports to the Audit Committee                                                        |     | PCompensation Committee retains an independent compensation consultant                                        |

| Stockholder Rights |     |                                                  |     |                                                                                                 |
|                    |     | PNo poison pill in place                         |     | PRobust stockholder engagement process (see “Stockholder Engagement and Outreach” sectionbelow) |
|                    |     | POne vote for each share and no non-voting stock |     | PAnnual “Say-on-Pay” vote                                                                       |

<div align='center'>7</div>

TABLE OF CONTENTS

#### Stockholder Engagement and Outreach
We recognize the importance of transparent communication with our stockholders and responding to their feedback. Beginning in the fall of 2024, we launched an extensive stockholder engagement campaign to ensure that stockholders had an opportunity to provide feedback on the Company’s board composition, corporate governance practices and executive compensation program, as well as any other topics of concern.

During the off season stockholder engagement program, we contacted stockholders representing more than 50% of our total shares outstanding to seek their